22 Feb 2017 - Singapore Business Review
For starters, it is still seeing a drop in medical tourism. For the analysts at CIMB, it is too premature to start turning positive on Raffles Medical Group, seeing that the 1.3% full-year growth is not something to spark a turnaround. According to CIMB, the group's 4Q16 top line growth was weak amidst ...
sgx:r01